Redalyc.Lactobacillus Paracasei Subsp. Paracasei F19; A

Total Page:16

File Type:pdf, Size:1020Kb

Redalyc.Lactobacillus Paracasei Subsp. Paracasei F19; A Nutrición Hospitalaria ISSN: 0212-1611 info@nutriciónhospitalaria.com Grupo Aula Médica España Di Cerbo, Alessandro; Palmieri, Beniamino Lactobacillus Paracasei subsp. Paracasei F19; a farmacogenomic and clinical update Nutrición Hospitalaria, vol. 28, núm. 6, noviembre-diciembre, 2013, pp. 1842-1850 Grupo Aula Médica Madrid, España Available in: http://www.redalyc.org/articulo.oa?id=309230209011 How to cite Complete issue Scientific Information System More information about this article Network of Scientific Journals from Latin America, the Caribbean, Spain and Portugal Journal's homepage in redalyc.org Non-profit academic project, developed under the open access initiative 11. LACTOBACILLUS_01. Interacción 05/12/13 12:06 Página 1842 Nutr Hosp. 2013;28(6):1842-1850 ISSN 0212-1611 • CODEN NUHOEQ S.V.R. 318 Revisión Lactobacillus Paracasei subsp. Paracasei F19; a farmacogenomic and clinical update Alessandro Di Cerbo1* and Beniamino Palmieri2 1Department of Clinical Microbiology. 2Department of General Surgery and Surgical Specialties. University of Modena e Reggio Emilia. Modena. Italy. Abstract LACTOBACILLUS PARACASEI SYBSP. PARACASEI F19; UNA ACTUALIZACIÓN DE Introduction: Many reports in literature have under- FARMACOGENOMIC Y CLÍNICA lined particular features of Lactobacillus paracasei subsp paracasei F19, however a critical review of main clinical Resumen outcomes has not been performed so far. Objectives: This review summarizes the most relevant Introducción: Muchas notificaciones en la bibliografía reports, in terms of clinical benefits, of Lactobacillus han puesto de manifiesto las características particulares paracasei subsp paracasei F19 administration reviewing del Lactobacillus paracasei, subespecie paracasei F19; sin it’s historical background and outlining new interesting embargo, la revisión crítica de los principales resultados perspectives in clinical practice. clínicos aún no se ha realizado. Methods: We searched Pubmed/Medline using the Objetivos: Esta revisión resume los artículos más rele- terms “ Lactobacillus paracasei subsp paracasei F19”. All vantes, en términos de beneficios clínicos, sobre adminis- clinical and experimental articles on the use of Lactobaci- tración del Lactobacillus paracasei, subespecie paracasei llus paracasei subsp paracasei F19 were included. F19, revisando su historia y recalcando nuevas perspecti- Results and discussion: The genetic stability of F19, the vas interesantes sobre su uso en la práctica clínica. most relevant clinical claim, renders it’s administration Métodos: realizamos una búsqueda en Pubmed/Med- reliable and effective in immunocompromised people. line usado los términos “Lactobacillus paracasei subsp Adequate concentrations of this strain support a paracasei F19”. Se incluyeron todos los artículos experi- dose/effect strategy ranging between NF B host macro - mentales que empleasen el Lactobacillus paracasei, subes- phage activation to pathogenic bacteria overgrowth pecie paracasei F19. control as well as to fine interaction with the gut nerve Resultados y discusión: La estabilidad genética de F19, endings. Moreover preliminary results from our lab su característica clínica más relevante, hace que su admi- support the formulation of F19 encapsulated with lyophi- nistración sea fiable y eficaz en personas inmunosuprimi- lized HA in patients with IBD due to both an increased das. Las concentraciones adecuadas de esta cepa apoyan mucous-strain adherence and a possible enhanced strain una estrategia de dosis/efecto que varía entre la activa- proliferation and maintenance. ción de los macrófagos del hospedador hasta un control Conclusions: Further experiments are required to del sobrecrecimiento de bacterias patógenas, así como overcome the lack of informations about this new formu- una adecuada interacción con las terminaciones nervio- lation for IBD management. sas intestinales. Además, los resultados preliminares de nuestro laboratorio apoyan la formulación encapsulada (Nutr Hosp. 2013;28:1842-1850) de Lactobacillus F19 con AH liofilizada en pacientes con DOI: 10.3305/nh.2013.28.6.6831 EII debido a una mayor adherencia de la cepa a la mucosa Key words: Lactobacillus paracasei subsp paracasei F19. y un posible favorecimiento de la proliferación y manteni- Lactic acid bacteria. Probiotic. miento de la cepa. Conclusiones: Se necesitan experimentos adicionales para paliar el déficit de información acerca de esta nueva formulación para el tratamiento de la EII. (Nutr Hosp. 2013;28:1842-1850) DOI: 10.3305/nh.2013.28.6.6831 Palabras clave: Lactobacillus paracasei subespecie F19. Bacterias acidolácticas. Probióticos. Correspondence: Alessandro Di Cerbo. E-mail: [email protected] Recibido: 22-V-2013. 1.ª Revisión: 3-VII-2013 Aceptado: 18-IX-2013. 1842 11. LACTOBACILLUS_01. Interacción 05/12/13 12:06 Página 1843 Abbreviations the ability to transcribe NF B to the nucleus of macrophages have made this lactobacillus a reason- L: Lactobacillus. able candidate for a probiotic product development7. LAB: lactic acid bacteria. F19: L. paracasei subsp paracasei F19. H. pylori: Helicobacter pylori. State of the art P. pentosaceus: Pediococcus pentosaceus. L. mesenteroides: Leuconostoc mesenteroides. F19 was isolated, for the first time, from the deep C. difficile: Clostridium difficile. colonic mucus layer of patients without gastroin- B: Bifidobacterium. testinal disease who were admitted to the Sabbatsberg EEC: enteroinvasive Escherichia coli. Hospital of Stockholm in 20027. Then it was included HA: hyaluronic acid. in the multicentre European project PROBDEMO, E. coli: Escherichia coli. which involved volunteers from Finland and Sweden, P. aeruginosa: Pseudomonas aeruginosa. where its gastric survival ability was assessed and where strains closely related to F19 were observed in the intestinal tract of a small percentage of volunteers8. Introduction Within the PROBDEMO project human pilot studies, based on the F19 strain, have been conducted. The Lactobacillus casei (L. casei) group is mainly One involved 61 healthy swedish infants and 30 elderly composed of lactic acid bacteria (LAB) such as Lacto- that were randomly assigned to receive or gelatin bacillus zeae (L. zeae), L. casei, Lactobacillus para- capsules containing 1×1010 CFU of F19 in corn starch casei (L. paracasei) and Lactobacillus rhamnosus (L. or corn starch only for 12 weeks9. Fecal samples from rhamnosus) widely used in dairy products and lactic infants treatment group (n = 30), collected before, beverages and whose major end product of sugar during (at 2-3 weeks) and 2 weeks after administration, fermentation is lactic acid. These bacteria are also revealed an increase of F19 in 6/30 and a reduction of gram-positive, nonsporing, catalase-negative ,devoid 17% of Clostridium difficile (C. difficile) population. of cytochromes and of nonaerobic habit but are aerotol- However the elderly treatment group (n = 13) did not erant, unpleasant, acid-tolerant and strictly fermenta- evidence substantial changes in terms of both micro- tive1. Studies on the electrostatic cell surface properties bial colonization and, as for the infants, Helicobacter revealed a pH-dependent configuration with elec- pylori (H. pylori) eradication. The overall results indi- trophoretic mobility progressively decreasing for cated the ability of F19 to survive through the gastroin- lower pH values for the Lactobacillus casei subsp. testinal tract and in 8-20% to be enclosed in the micro- casei (L. casei subsp. casei) and Lactobacillus para- biota for several weeks as a part of the normal casei subsp. paracasei (L. paracasei subsp. paracasei) microflora. Another trial, still based on the assessment strains until the isoelectric point (IEP = 4). The pH of gastric survival and mucosal adhesion of F19, indi- variations might be linked to cell wall chemical cated that it was both in the lumen and adhered to the composition with adhesion mechanism during gastric mucosa of the colon (0.9×104 CFU) following 12 day transit2. consumption in 5 individuals10. Potential side-effects of The taxonomic position and nomenclature of the L. probiotic consumption, such as intestinal discomfort, casei group has been long time debated3. In the past L. increased flatulence and changes in stool consistency casei group had been one species divided into five and frequency, were monitored. All studies reported no subspecies: the L. casei subspecies casei, alactosus, adverse effects. pseudoplantarum, tolerans and rhamnosus4, but in 1989 A questionable issue that has been extensively Collins et al. introduced a reclassification by introducing studied for the F19 is the genetic stability assessment, two new species: L. paracasei and L. rhamnosus and especially in order to guarantee consumers of the tranferring subspecies L. casei subspecies casei to the quality of probiotic11-12. The stability of three extrachro- species L. casei without any subspecies5. L. paracasei mosomal elements (plasmids) within F19 was care- comprised two subspecies: the subspecies Lactobacillus fully checked in each step of the industrial reproduc- including L. casei subspecies alactosus and pseudoplan- tion process and their genetic profile was compared tarum and the subspecies tolerans from the L. casei with those determined in the same strain 6 years earlier. subspecies with the same name. At the end of the study no selection of cured derivatives L. paracasei subsp paracasei F19 (F19) belongs to was detected and all plasmids resulted unaltered. the homofermentative family of lactic acid
Recommended publications
  • The Influence of Probiotics on the Firmicutes/Bacteroidetes Ratio In
    microorganisms Review The Influence of Probiotics on the Firmicutes/Bacteroidetes Ratio in the Treatment of Obesity and Inflammatory Bowel disease Spase Stojanov 1,2, Aleš Berlec 1,2 and Borut Štrukelj 1,2,* 1 Faculty of Pharmacy, University of Ljubljana, SI-1000 Ljubljana, Slovenia; [email protected] (S.S.); [email protected] (A.B.) 2 Department of Biotechnology, Jožef Stefan Institute, SI-1000 Ljubljana, Slovenia * Correspondence: borut.strukelj@ffa.uni-lj.si Received: 16 September 2020; Accepted: 31 October 2020; Published: 1 November 2020 Abstract: The two most important bacterial phyla in the gastrointestinal tract, Firmicutes and Bacteroidetes, have gained much attention in recent years. The Firmicutes/Bacteroidetes (F/B) ratio is widely accepted to have an important influence in maintaining normal intestinal homeostasis. Increased or decreased F/B ratio is regarded as dysbiosis, whereby the former is usually observed with obesity, and the latter with inflammatory bowel disease (IBD). Probiotics as live microorganisms can confer health benefits to the host when administered in adequate amounts. There is considerable evidence of their nutritional and immunosuppressive properties including reports that elucidate the association of probiotics with the F/B ratio, obesity, and IBD. Orally administered probiotics can contribute to the restoration of dysbiotic microbiota and to the prevention of obesity or IBD. However, as the effects of different probiotics on the F/B ratio differ, selecting the appropriate species or mixture is crucial. The most commonly tested probiotics for modifying the F/B ratio and treating obesity and IBD are from the genus Lactobacillus. In this paper, we review the effects of probiotics on the F/B ratio that lead to weight loss or immunosuppression.
    [Show full text]
  • Bacillus Subtilis Enhances Production of Paracin1.7, a Bacteriocin Produced by Lactobacillus Paracasei HD1-7, Isolated from Chinese Fermented Cabbage
    Ann Microbiol (2014) 64:1735–1743 DOI 10.1007/s13213-014-0817-z ORIGINAL ARTICLE Bacillus subtilis enhances production of Paracin1.7, a bacteriocin produced by Lactobacillus paracasei HD1-7, isolated from Chinese fermented cabbage Jingping Ge & Baozhu Fang & Yang Wang & Gang Song & Wenxiang Ping Received: 11 September 2013 /Accepted: 14 January 2014 /Published online: 20 February 2014 # Springer-Verlag Berlin Heidelberg and the University of Milan 2014 Abstract Lactobacillus paracasei HD1-7 (CCTCCM Keywords Lactobacillus paracasei . Bacteriocin . 205015), isolated from Chinese sauerkraut fermentation broth, Co-culture experiments . Quorum sensing was found to contain the bacteriocin Paracin1.7, which pos- sesses broad-spectrum antibacterial activity. We examined the relationship between bacteriocin production by L. paracasei Introduction strain HD1-7 and the cell density of co-cultured bacteria. The cells and supernatants from cultures of different densities of Many bacteria are capable of producing bacteriocins, which five microbes, four bacteria, and a yeast were co-cultured with are ribosomally-synthesized peptides or proteins that have L. paracasei HD1-7, and the change in Paracin1.7 levels in the antimicrobial activity against closely related bacterial strains culture broth was measured by the agar-well diffusion meth- or broad-spectrum inhibitory activity against other microbes od. When the initial cell density of the L. paracasei HD1-7 (Tagg et al. 1976;Boman1995; Hancock and Lehrer 1998). inoculum was 106 CFU/mL, the strain did not produce bacte- The use of lactic acid bacteria (LAB) in fermented foods has a riocin, and this was termed the threshold concentration. The long history due to the benefits of their nutritional, organolep- five species of microbes tested were grown with added culture tic, and antimicrobial activities (Klaenhammer 1993).
    [Show full text]
  • Probiotic Lactobacillus Paracasei Expressing a Nucleic Acid
    Article Probiotic Lactobacillus Paracasei Expressing a Nucleic Acid-Hydrolyzing Minibody (3D8 Scfv) Enhances Probiotic Activities in Mice Intestine as Revealed by Metagenomic Analyses Seungchan Cho 1,†, Dongjun Kim 1, Yongjun Lee 1, Eui-Joon Kil 1, Mun-Ju Cho 1, Sung-June Byun 2, Won Kyong Cho 3,* and Sukchan Lee 1,* 1 Department of Genetic Engineering, Sungkyunkwan University, 2066, Seobu-ro, Jangan-gu, Suwon 16419, Korea; [email protected] (S.C.); [email protected] (D.K.); [email protected] (Y.L.); [email protected] (E.-J.K.); [email protected] (M.-J.C.) 2 Animal Biotechnology Division, National Institute of Animal Science (NIAS), Rural Development Administration (RDA), 1500, Kongjwipatjwi-ro, Iseomyeon, Wanju 55365, Korea; [email protected] 3 Research Institute of Agriculture and Life Sciences, College of Agriculture and Life Sciences, Seoul National University, 1, Gwanak-ro, Gwanak-gu, Seoul 08826, Korea * Correspondence: [email protected] (W.K.C.); [email protected] (S.L.) † Present address: Department of Microbiology, College of Medicine, Korea University, 73, Inchon-ro, Seoul 08826, Korea. Received: 8 March 2018; Accepted: 17 May 2018; Published: 29 May 2018 Abstract: Probiotics are well known for their beneficial effects for animals, including humans and livestock. Here, we tested the probiotic activity of Lactobacillus paracasei expressing 3D8 scFv, a nucleic acid-hydrolyzing mini-antibody, in mice intestine. A total of 18 fecal samples derived from three different conditions at two different time points were subjected to high-throughput 16S ribosomal RNA (rRNA) metagenomic analyses. Bioinformatic analyses identified an average of 290 operational taxonomic units. After administration of L.
    [Show full text]
  • Presence of Two Lactobacillus and Bifidobacterium Probiotic Strains in the Neonatal Ileum
    The ISME Journal (2008) 2, 83–91 & 2008 International Society for Microbial Ecology All rights reserved 1751-7362/08 $30.00 www.nature.com/ismej ORIGINAL ARTICLE Presence of two Lactobacillus and Bifidobacterium probiotic strains in the neonatal ileum Rebecca Wall1,2,3, Seamus Gerard Hussey4,5, C Anthony Ryan4, Martin O’Neill5, Gerald Fitzgerald2,3,1,2, Catherine Stanton1,2 and R Paul Ross1,2 1Department of Biotechnology, Teagasc, Moorepark Food Research Centre, Fermoy, Co. Cork, Ireland; 2Alimentary Pharmabiotic Centre, Cork, Ireland; 3Department of Microbiology, University College, Cork, Ireland; 4Erinville Hospital and Department of Paediatrics and Child Health, University College, Cork, Ireland and 5Department of Paediatrics, Mayo General Hospital, Castlebar, Mayo, Ireland The overall purpose of this study was to examine the lactobacilli and bifidobacteria microbiota in the human ileum at a very early stage of life. Ileostomy effluents from two infants, taken at different time points, were plated on Lactobacillus selective agar and cys-MRS containing mupirocin to select for bifidobacteria. In one case, a stool sample following ileostomy reversal was subsequently analyzed microbiologically. Pulse-field gel electrophoresis and 16S rRNA sequencing was used to investigate the cultivable population of bifidobacteria and lactobacilli and denaturing gradient gel electrophor- esis (DGGE) to examine the non-cultivable population. The probiotic strain, Lactobacillus paracasei NFBC 338, was recovered at both time points from one of the infants and dominated in the small intestine for a period of over 3 weeks. Moreover, the probiotic strain, B. animalis subsp. lactis Bb12, was obtained from the other infant. This study shows the presence of two known probiotic strains in the upper intestinal tract at an early stage of human life and thus provides some evidence for their ability to colonize the infant small intestine.
    [Show full text]
  • The Effectiveness of Probiotic Lactobacillus Rhamnosus
    nutrients Article The Effectiveness of Probiotic Lactobacillus rhamnosus and Lactobacillus casei Strains in Children with Atopic Dermatitis and Cow’s Milk Protein Allergy: A Multicenter, Randomized, Double Blind, Placebo Controlled Study Bozena˙ Cukrowska 1,*, Aldona Ceregra 2, Elzbieta˙ Maciorkowska 3, Barbara Surowska 4, Maria Agnieszka Zegadło-Mylik 5, Ewa Konopka 1, Ilona Trojanowska 1, Magdalena Zakrzewska 3, Joanna Beata Bierła 1 , Mateusz Zakrzewski 3, Ewelina Kanarek 1 and Ilona Motyl 6 1 Department of Pathomorphology, the Children’s Memorial Health Institute, Aleja Dzieci Polskich 20, 04-730 Warsaw, Poland; [email protected] (E.K.); [email protected] (I.T.); [email protected] (J.B.B.); [email protected] (E.K.) 2 Outpatient Allergology and Dermatology Clinic, Patriotów St. 100, 04-844 Warsaw, Poland; [email protected] 3 Department of Developmental Age Medicine and Paediatric Nursing, Faculty of Health Sciences, Medical University of Bialystok, Szpitalna St. 37, 15-295 Białystok, Poland; [email protected] (E.M.); Citation: Cukrowska, B.; Ceregra, A.; [email protected] (M.Z.); [email protected] (M.Z.) 4 Outpatient Allergology Clinic, the Children’s Memorial Health Institute, Aleja Dzieci Polskich 20, Maciorkowska, E.; Surowska, B.; 04-730 Warsaw, Poland; [email protected] Zegadło-Mylik, M.A.; Konopka, E.; 5 Outpatient Dermatology Clinic, Chodakowska St. 8, 96-503 Sochaczew, Poland; [email protected] Trojanowska, I.; Zakrzewska, M.; 6 Department of Environmental Biotechnology, Lodz University of Technology, Wólcza´nska171/173, Bierła, J.B.; Zakrzewski, M.; et al. The 90-924 Łód´z,Poland; [email protected] Effectiveness of Probiotic Lactobacillus * Correspondence: [email protected]; Tel.: +48-22-815-19-69 rhamnosus and Lactobacillus casei Strains in Children with Atopic Abstract: Probiotics seem to have promising effects in the prevention and treatment of allergic Dermatitis and Cow’s Milk Protein conditions including atopic dermatitis (AD) and food allergy.
    [Show full text]
  • Isolation of a Lactobacillus Paracasei Strain with Probiotic Attributes from Kefir Grains
    biomedicines Article Isolation of a Lactobacillus paracasei Strain with Probiotic Attributes from Kefir Grains Stavros Plessas 1,* , Despoina Eugenia Kiousi 2, Marina Rathosi 2, Athanasios Alexopoulos 1, Yiannis Kourkoutas 3 , Ioanna Mantzourani 1, Alex Galanis 2 and Eugenia Bezirtzoglou 4 1 Laboratory of Food Processing, Faculty of Agricultural Development, Democritus University of Thrace, 68200 Orestiada, Greece; [email protected] (A.A.); [email protected] (I.M.) 2 Department of Molecular Biology and Genetics, Faculty of Health Sciences, Democritus University of Thrace, 68100 Alexandroupolis, Greece; [email protected] (D.E.K.); [email protected] (M.R.); [email protected] (A.G.) 3 Laboratory of Applied Microbiology and Biotechnology, Department of Molecular Biology and Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece; [email protected] 4 Laboratory of Hygiene and Environmental Protection, Medical School, Faculty of Health Sciences, Democritus University of Thrace, 68100 Alexandroupolis, Greece; [email protected] * Correspondence: [email protected]; Tel./Fax: +30-25520-41141 Received: 23 November 2020; Accepted: 9 December 2020; Published: 11 December 2020 Abstract: Kefir is a rich source of potentially probiotic bacteria. In the present study, firstly, in vitro screening for probiotic characteristics of ten lactic acid bacteria (LAB) isolated from kefir grains was performed. Strain AGR 4 was selected for further studies. Molecular characterization of strain AGR 4, confirmed that AGR 4 belongs to the Lactobacillus paracasei (reclassified to Lacticaseibacillus paracasei subsp. paracasei) species. Further testing revealed that L. paracasei AGR 4 displayed adhesion capacity on human adenocarcinoma cells, HT-29, similar to that of the reference strain, L.
    [Show full text]
  • Exclusive Use of Digital PCR Allows an Absolute Assay of Heat-Killed
    www.nature.com/scientificreports OPEN Exclusive use of digital PCR allows an absolute assay of heat‑killed Lactobacilli in foods targeting multiple copies of 16S rDNA Takashi Soejima*, Miyuki Tanaka, Koji Yamauchi & Fumiaki Abe The real‑time PCR (qPCR) and digital PCR (dPCR) to amplify a single‑copy of house‑keeping genes (i.e., hsp60, pheS or tuf) are used for the assay of limited microbial species. In general, with a single‑ copy gene, there are obviously varied DNA sequences for even the same microbial species, which could cause difculties with design of primers and probes for PCR when targeting various single copy genes. In general, for identifcation by dPCR (as a representative case: Lactobacillus paracasei), accumulated DNA sequence information of 16S rDNA, which is much more frequently used, should be targeted. In contrast, next-generation sequencing revealed that there are fve copies of 16S rDNA in a live L. paracasei MCC1849. Therefore, we aimed to reveal, if heat-killed L. paracasei supplemented in nutritional foods that aid the host immune system have the relevant fve copies per chromosomal DNA, and if the relevant copies remain unchanged on the same chromosomal DNA or remain to be diferent chromosomal DNA fragments. So, we revealed the actual distribution of the potential original fve copies of 16S rDNA using our innovative dPCR, in which both 16S rDNA and hsp60 genes were simultaneously elongated. The molecular ratios of 16S rDNA/hsp60 dispersed in the dPCR chip were then estimated. The 16S rDNA/hsp60 molecular ratios of the heat‑killed L. paracasei in foods, resultantly ranged from 5.0 to 7.2, being the same or higher than that of the fve copies determined by next-generation sequencing.
    [Show full text]
  • Deoxyribonucleic Acid Homology Studies of Lactobacillus Casei, Lactobacillus Paracasei Sp
    INTERNATIONALJOURNAL OF SYSTEMATICBACTERIOLOGY, Apr. 1989, p. 105-108 Vol. 39, No. 2 0020-7713/89/020105-04$02.oo/o Deoxyribonucleic Acid Homology Studies of Lactobacillus casei, Lactobacillus paracasei sp. nov., subsp. paracasei and subsp. tolerans, and Lactobacillus rhamnosus sp. nov., comb. nov. MATTHEW D. COLLINS,* BRIAN A. PHILLIPS, AND PAOLO ZANONI Agricultural Food Research Council Institute of Food Research, Reading Laboratory, ShinJield, Reading RG2 9AT, England Deoxyribonucleic acid (DNA)-DNA hybridizations were performed on strains of Lactobacillus casei. Our results indicate that this species as presently constituted is genomically very heterogeneous. The majority of strains designated L. casei subsp. casei, together with members of L. casei subsp. alactosus, L. casei subsp. pseudoplantarum, and L. casei subsp. tolerans, exhibited high levels of DNA relatedness with each other but were distinct from the type strain of L. casei subsp. casei. Strains of L. casei subsp. rhamnosus also formed a genomically homogeneous group unrelated to all members of the other L. casei subspecies examined. On the basis of the present and previous findings we suggest that members of L. casei subsp. alactosus, L. casei subsp. pseudoplantarum, and L. casei subsp. tolerans and the majority of L. casei subsp. casei strains be given separate species status, for which we propose the names L. paracasei sp. nov., L. paracasei subsp. paracasei (type strain, NCDO 151), and L. paracusei subsp. tolerans (type strain ATCC 25599). We also propose that L. casei subsp. rhamnosus be elevated to species status, as L. rhamnosus sp. nov. (type strain, ATCC 7469). Lactobacillus casei is a facultatively heterofermentative using the API 50CH system (API-Biomerieux) according to species which is found in many habitats (e.g., dairy prod- the instructions of the manufacturer.
    [Show full text]
  • Comparative Genomic and Metabolic Analysis of Three Lactobacillus
    Stefanovic and McAuliffe BMC Genomics (2018)19:205 https://doi.org/10.1186/s12864-018-4586-0 RESEARCH ARTICLE Open Access Comparative genomic and metabolic analysis of three Lactobacillus paracasei cheese isolates reveals considerable genomic differences in strains from the same niche Ewelina Stefanovic* and Olivia McAuliffe Abstract Background: Strains of Lactobacillus paracasei are present in many diverse environments, including dairy and plant materials and the intestinal tracts of humans and animals. Their adaptation to various niches is correlated to intra-species diversity at the genomic and metabolic level. In this study, we compared the genome sequences of three L. paracasei strains isolated from mature Cheddar cheeses, two of which (DPC4206 and DPC4536) shared the same genomic fingerprint by PFGE, but demonstrated varying metabolic capabilities. Results: Genome sizes varied from 2.9 Mbp for DPC2071, to 3.09 Mbp for DPC4206 and 3.08 Mpb for DPC4536. The presence of plasmids was a distinguishing feature between the strains with strain DPC2071 possessing an unusually high number of plasmids (up to 11), while DPC4206 had one plasmid and DPC4536 harboured no plasmids. Each of the strains possessed specific genes not present in the other two analysed strains. The three strains differed in their abundance of sugar-converting genes, and in the types of sugars that could be used as energy sources. Genes involved in the metabolism of sugars not usually connected with the dairy niche, such as myo-inositol and pullulan were also detected, but strains did not utilise these sugars. The genetic content of the three strains differed in regard to specific genes for arginine and sulfur-containing amino acid metabolism and genes contributing to resistance to heavy metal ions.
    [Show full text]
  • Effect of Lactobacillus Reuteri on Intestinal Microflora and Immune Parameters
    bioRxiv preprint doi: https://doi.org/10.1101/312678; this version posted May 2, 2018. The copyright holder has placed this preprint (which was not certified by peer review) in the Public Domain. It is no longer restricted by copyright. Anyone can legally share, reuse, remix, or adapt this material for any purpose without crediting the original authors. 1 Effect of Lactobacillus reuteri on intestinal microflora and immune parameters: 2 involvement of sex differences 3 Jiayi He1, Lingyi Wu1, Zhen Wu1*, Daodong Pan1,2†, Yuxing Guo2, Xiaoqun Zeng1, 4 Liwei Lian3 5 6 Running title: Sex differences to the consumption of L. reuteri 7 1 Key Laboratory of Animal Protein Deep Processing Technology of Zhejiang, Marine 8 Science School, Ningbo University, Ningbo, Zhejiang, P. R. China 9 2 Department of Food Science and Nutrition, Ginling College, Nanjing Normal 10 University, Nanjing, P. R. China 11 3 Ningbo Dairy Group, Ningbo, 315211, Zhejiang, P.R. China 12 13 14 15 16 17 *Corresponding authors: Zhen Wu, Key Laboratory of Animal Protein Food Deep Processing Technology of Zhejiang Province, Ningbo University. Tel. +86 13857472882; E-mail: [email protected]; †Co-corresponding author: Daodong Pan, Key Laboratory of Animal Protein Food Deep Processing Technology of Zhejiang Province, Ningbo University. Tel.: + 86- 574 - 87600737; fax: + 86 – (0)574 - 87608347. E-mail: [email protected]. 1 bioRxiv preprint doi: https://doi.org/10.1101/312678; this version posted May 2, 2018. The copyright holder has placed this preprint (which was not certified by peer review) in the Public Domain. It is no longer restricted by copyright.
    [Show full text]
  • Identification and Phylogenetic Studies of a New Probiotic
    ACTA SCIENTIFIC NUTRITIONAL HEALTH (ISSN:2582-1423) Volume 4 Issue 3 March 2020 Research Article Lactobacillus spp. Identification and Phylogenetic Studies of a New Probiotic Ahmed R Awd1, Khater A Khater1 and Egyptian Ahmed IsolateI Ismail 2,3Based* on 16s rRNA Gene 1Dairy Science and Technology Department, Faculty of Agricultural, Al-Azhar Received: University, Egypt Published: February 17, 2020 2 Ahmed I Ismail., Biotechnology Department, Faculty of Agriculture, University of Al-Azhar, Cairo, February 26, 2020 et al. Egypt © All rights are reserved by 3Public Health Department, College of Applied Medical Sciences, Majmaah University, Al-Majmaah, Saudi Arabia *Corresponding Author: Ahmed I Ismail, Biotechnology Department, Faculty of Agriculture, University of Al-Azhar, Cairo, Egypt and Public Health Department, College ofDOI: Applied Medical Sciences, Majmaah University, Al-Majmaah, Saudi Arabia. 10.31080/ASNH.2020.04.0654 Abstract Lactobacillus Lactobacillus represents one of the most important genera of human and animal intestinal tract. They are used in dairy and non- dairy probiotics foods to restore the intestinal microflora, which provides a health benefit. strains were phenotypically identified and described using biochemical features and kits such as the API 50 CH system. Conventional biochemical and physiologi- cal studies have certain limitations when discriminating against large numbers of isolates with similar physiological characteristics. They are generally unreliable, and consuming money, time, and effort. There are many studies have focused on the rapid identifica- tion of molecular biology techniques for the rapid identification and detection of lactobacilli. In this study, we examined five pairs L. casei, L. rhamnosus L. gasseri of primers on complex communities to facilitate the examination of complex micro-ecosystems.
    [Show full text]
  • Lactobacillus Paracasei CNCM I-3689 Reduces Vancomycin
    www.nature.com/scientificreports OPEN Lactobacillus paracasei CNCM I-3689 reduces vancomycin-resistant Enterococcus persistence and Received: 9 October 2017 Accepted: 13 March 2018 promotes Bacteroidetes resilience Published: xx xx xxxx in the gut following antibiotic challenge Laureen Crouzet1,4, Muriel Derrien2, Claire Cherbuy1, Sandra Plancade3, Mélanie Foulon1, Benjamin Chalin1, Johan E. T. van Hylckama Vlieg2,5, Gianfranco Grompone2,6, Lionel Rigottier-Gois1 & Pascale Serror1 Enterococci, in particular vancomycin-resistant enterococci (VRE), are a leading cause of hospital- acquired infections. Promoting intestinal resistance against enterococci could reduce the risk of VRE infections. We investigated the efects of two Lactobacillus strains to prevent intestinal VRE. We used an intestinal colonisation mouse model based on an antibiotic-induced microbiota dysbiosis to mimic enterococci overgrowth and VRE persistence. Each Lactobacillus spp. was administered daily to mice starting one week before antibiotic treatment until two weeks after antibiotic and VRE inoculation. Of the two strains, Lactobacillus paracasei CNCM I-3689 decreased signifcantly VRE numbers in the feces demonstrating an improvement of the reduction of VRE. Longitudinal microbiota analysis showed that supplementation with L. paracasei CNCM I-3689 was associated with a better recovery of members of the phylum Bacteroidetes. Bile salt analysis and expression analysis of selected host genes revealed increased level of lithocholate and of ileal expression of camp (human LL-37) upon L. paracasei CNCM I-3689 supplementation. Although a direct efect of L. paracasei CNCM I-3689 on the VRE reduction was not ruled out, our data provide clues to possible anti-VRE mechanisms supporting an indirect anti-VRE efect through the gut microbiota.
    [Show full text]